Barrett Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,500
Closed -$171K 375
2018
Q4
$171K Hold
1,500
0.01% 146
2018
Q3
$173K Hold
1,500
0.01% 165
2018
Q2
$155K Hold
1,500
0.01% 166
2018
Q1
$148K Hold
1,500
0.01% 168
2017
Q4
$127K Hold
1,500
0.01% 182
2017
Q3
$115K Hold
1,500
0.01% 185
2017
Q2
$117K Hold
1,500
0.01% 186
2017
Q1
$108K Hold
1,500
0.01% 177
2016
Q4
$93K Hold
1,500
0.01% 186
2016
Q3
$97K Hold
1,500
0.01% 178
2016
Q2
$95K Hold
1,500
0.01% 177
2016
Q1
$87K Hold
1,500
0.01% 175
2015
Q4
$81K Hold
1,500
0.01% 180
2015
Q3
$76K Hold
1,500
0.01% 186
2015
Q2
$85K Hold
1,500
0.01% 192
2015
Q1
$108K Hold
1,500
0.01% 175
2014
Q4
$84K Hold
1,500
0.01% 212
2014
Q3
$74K Hold
1,500
0.01% 223
2014
Q2
$76K Buy
+1,500
New +$74.3K 0.01% 219

Other funds holding RMD

Barrett Asset Management's RMD Position: Q1 2019 in Review

Barrett Asset Management sold out of ResMed (RMD) in Q1 2019, closing a stake of 1,500 shares — an estimated $171K sold.

Barrett Asset Management first reported a position in RMD in Q2 2014 and held it in 19 quarters. The position peaked at $173K in Q3 2018. 477 funds tracked by Wall St. Rank hold RMD as of Q1 2019.

  • Barrett Asset Management reported no remaining ResMed position as of Q1 2019 after selling out during the quarter.
  • Barrett Asset Management sold 1,500 ResMed shares in Q1 2019, an estimated $171K.
  • Barrett Asset Management first reported a position in ResMed in Q2 2014 and held it in 19 quarters.
  • Barrett Asset Management's ResMed position peaked at $173K in Q3 2018.
  • 477 funds tracked by Wall St. Rank held ResMed as of Q1 2019.

Based on Barrett Asset Management's 13F filing for Q1 2019, filed 10 May 2019.